| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 70.49 | 0.4% | 12.7% |
| Total Income | 70.49 | 0.4% | 12.7% |
| Expenditure | 106.97 | 39.6% | 9.2% |
| PBT | — | ||
| Net Profit | -40.54 | 63.5% | 1.1% |
| OPM | -51.75% | 5.80pp | |
| NPM | -57.51% | 6.74pp | |
| EPS | -0.55 | 64.0% | 6.8% |
Health Catalyst Reports Q2 2026 Results
07 Aug 2026 · 7 Aug, 1:51 am
Summary
Health Catalyst reported second quarter 2026 revenue of $70.5 million, a 13% decrease year-over-year, with gross profit at $27.9 million, down 8%. However, gross margin improved to 40% from 38%, and Adjusted EBITDA saw a 6% increase to $9.9 million. The company recently completed the divestiture of Vitalware and fully repaid its credit facility debt, which CEO Ben Albert stated significantly improves the balance sheet and provides flexibility. Health Catalyst is focusing its resources on its core intelligence products designed to help health systems manage costs, advance clinical quality, and earn consumer loyalty.
Key Highlights
- 1
Total revenue for the three months ended June 30, 2026, was $70.5 million, a decrease of 13% compared to $80.7 million in the same period last year.
- 2
Gross profit for the quarter was $27.9 million, down 8% year-over-year from $30.3 million.
- 3
Gross margin improved to 40% from 38% in the prior year's second quarter.
- 4
Adjusted EBITDA for the quarter increased by 6% to $9.9 million, up from $9.3 million in the prior year.
- 5
The company expects full-year 2026 total revenue to be between $246 million and $249 million.
- 6
Full-year 2026 Adjusted EBITDA is projected to be between $18 million and $18.5 million.
Management Comments
Ben Albert
We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the midpoint of our adjusted EBITDA guidance. More importantly, we recently closed the Vitalware divestiture and fully repaid our credit facility debt, which significantly improves our balance sheet and provides flexibility to make measured near-term bets in the work we believe in most. After eighteen years working with health systems, we know how to drive outcomes. We believe our intelligence products can help them improve outcomes faster. That's the company we're working to build. We're excited about where we are headed. To us, powerful analytics are essential, and our expertise is built on 18 years of what actually works. What comes next is the part that we believe matters most: pairing that with knowing where to act, in what order, and with what impact, and the support to help make change stick. That's the problem we're working to solve, and we believe we are well-positioned to solve it.
Informational and educational content only. Not investment advice.